Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis.

Callebaut I, Vandewalle E, Hox V, Bobic S, Jorissen M, Stalmans I, De Vries A, Scadding G, Hellings PW.

Ann Allergy Asthma Immunol. 2012 Aug;109(2):141-6. doi: 10.1016/j.anai.2012.06.008.

PMID:
22840257
2.
4.

Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.

Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.

Curr Med Res Opin. 2009 Jun;25(6):1393-401. doi: 10.1185/03007990902890512.

PMID:
19419338
7.

Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.

Baroody FM, Logothetis H, Vishwanath S, Bashir M, Detineo M, Naclerio RM.

Am J Rhinol Allergy. 2013 Jan;27(1):48-53. doi: 10.2500/ajra.2013.27.3841.

PMID:
23406601
8.

Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.

Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF.

Allergy. 2007 Sep;62(9):1078-84.

10.

Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.

Di Lorenzo G, Gervasi F, Drago A, Esposito Pellitteri M, Di Salvo A, Cosentino D, Potestio M, Colombo A, Candore G, Mansueto S, Caruso C.

Clin Exp Allergy. 1999 Oct;29(10):1367-77.

PMID:
10520057
11.

Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study.

Palma-Carlos AG, Santos AS, Branco-Ferreira M, Pregal AL, Palma-Carlos ML, Bruno ME, Falagiani P, Riva G.

Allergol Immunopathol (Madr). 2006 Sep-Oct;34(5):194-8.

PMID:
17064648
12.

Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.

Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE.

J Allergy Clin Immunol. 2007 Jun;119(6):1430-7. Erratum in: J Allergy Clin Immunol. 2010 May;125(5):1068.

PMID:
17418384
13.

Mometasone furoate nasal spray relieves the ocular symptoms of seasonal allergic rhinoconjunctivitis.

Igarashi T, Nakazato Y, Kunishige T, Fujita M, Yamada Y, Fujimoto C, Okubo K, Takahashi H.

J Nippon Med Sch. 2012;79(3):182-9.

14.

Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis.

Kaszuba SM, Baroody FM, deTineo M, Haney L, Blair C, Naclerio RM.

Arch Intern Med. 2001 Nov 26;161(21):2581-7.

PMID:
11718589
15.

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.

Clin Exp Allergy. 2004 Feb;34(2):259-67. Erratum in: Clin Exp Allergy. 2004 Aug;34(8):1329.

PMID:
14987306
16.
17.
19.

Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.

Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W.

J Allergy Clin Immunol. 2001 Apr;107(4):627-33.

PMID:
11295650
20.
Items per page

Supplemental Content

Support Center